Recombinant Poliomyelitis vaccine (PBPV)
Poliomyelitis Prevention
Phase 1Active
Key Facts
About CanSino Biologics
A leading Chinese vaccine developer leveraging adenovirus vector technology to create innovative vaccines for global infectious disease prevention.
View full company profileTherapeutic Areas
Other Poliomyelitis Prevention Drugs
| Drug | Company | Phase |
|---|---|---|
| Sabin IPV | Sinovac Biotech | Approved in China |